| abstract |
The present disclosure relates to compounds, compositions, and methods of formula (I) for the treatment of hepatitis C virus (HCV) infection.n n n <Formula I>n n n n n n n n Wherein A and B are selected from phenyl and a 6-membered heteroaromatic ring containing 1, 2 or 3 nitrogen atoms; Provided that at least one of A and B is not phenyl.n n n Also disclosed are pharmaceutical compositions containing these compounds and methods of using these compounds in the treatment of HCV infection. |